Morgan Stanley Trims Celularity's Price Target to $5 From $8, Keeps Equalweight Rating
Morgan Stanley Trims Celularity's Price Target to $5 From $8, Keeps Equalweight Rating
摩根士丹利將Celularity的目標股價從8美元下調至5美元,保持同等權重評級
Unity Software(U.US) reported fourth-quarter financial results after the market close on Monday. Here's a rundown of the report.Q4 Earnings: Unity said fourth-quarter revenue increased 35% year-over-year to $609 million, beating the consensus estimate of $562.71 million. The company reported a quarterly loss of 66 cents per share.
登入免費觀看全文
登入/註冊